Skip to main content
. 2022 Mar 18;11(7):e022852. doi: 10.1161/JAHA.121.022852

Table 9.

Plasma Ceramide Levels Stratified by the Use of Lipid‐Lowering Therapy

Plasma ceramide No lipid therapy* (n=60) Lipid‐lowering therapy* (n=60) P value
18:0, μmol/L 0.08 (0.07; 0.12) 0.10 (0.07; 0.13) 0.096
16:0, μmol/L 0.29 (0.26; 0.35) 0.28 (0.24; 0.31) 0.305
24:1, μmol/L 0.78 (0.69; 0.93) 0.77 (0.63; 0.96) 0.813
24:0, μmol/L 3.05 (2.73; 3.87) 2.93 (2.68; 3.43) 0.950
16:0/24:0 0.09 (0.08; 0.11) 0.09 (0.08; 0.11) 0.337
18:0/24:0 0.03 (0.02; 0.04) 0.03 (0.03; 0.04) 0.037
24:1/24:0 0.25 (0.22; 0.31) 0.26 (0.21; 0.32) 0.620
*

Data are presented as median (interquartile range).